SRL
ARCT icon

Scientech Research LLC’s Arcturus Therapeutics ARCT Stock Holding History

Scientech Research LLC’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,377
Closed -$374K – 606
2024
Q2 		$374K Buy
+15,377
New +$466K 0.08% 400

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scientech Research LLC's ARCT Position: Q3 2024 in Review

Scientech Research LLC sold out of Arcturus Therapeutics (ARCT) in Q3 2024, closing a stake of 15,377 shares — an estimated $374K sold.

Scientech Research LLC first reported a position in ARCT in Q2 2024 and held it in 1 quarter. The position peaked at $374K in Q2 2024. 164 funds tracked by Wall St. Rank hold ARCT as of Q3 2024.

  • Scientech Research LLC reported no remaining Arcturus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Scientech Research LLC sold 15,377 Arcturus Therapeutics shares in Q3 2024, an estimated $374K.
  • Scientech Research LLC first reported a position in Arcturus Therapeutics in Q2 2024 and held it in 1 quarter.
  • Scientech Research LLC's Arcturus Therapeutics position peaked at $374K in Q2 2024.
  • 164 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2024.

Based on Scientech Research LLC's 13F filing for Q3 2024, filed 14 Nov 2024.